ITC completes acquisition of 100% stake of Sresta Natural Bioproducts for ₹400 crore

The acquisition was completed on a cash-free, debt-free basis, with an upfront consideration of ₹400 crore and a potential additional payout of up to ₹72.5 crore over the next 24 months, subject to agreed conditions. Shares of ITC Ltd ended at ₹413.90, down by ₹7.05, or 1.67%, on the BSE.

Leave a Reply

Your email address will not be published. Required fields are marked *